Relation between pre-procedural glucose levels and incidence of major adverse cardiac events in chronic kidney disease patients without established diabetes undergoing percutaneous coronary intervention212-220
Effects of pioglitazone on arteriosclerotic-related factors and short term prognosis in patients with coronary disease and diabetes221-226
Contrast-induced nephropathy after a second percutaneous coronary intervention in patients with chronic kidney disease227-240
Early in vivo experience with tissue-engineered heart valve leaflets from autologous bone marrow-derived cells248-256
A 17-year-old Male with Duchenne muscular dystrophy complicated with dilated cardiomyopathy and large left ventricular mural thrombosis262-267